French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
DPC France has withdrawn lots 117 (per 31.08.04) and 118 (per 31.10.04) from the market for the in vitro diagnostic medical device known as IMMULITE 2000 intact PTH - references L2KPP2 and L2KPP6, following the observation in some cases of an increase in the values of the results. This device is intended for the assay, on the Immulite 2000 analyzer, of the intact parathyroid hormone (Parathormone, intact PTH) in the serum.